Medeon Biodesign, Inc. (TPEX:6499)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
88.30
+5.00 (6.00%)
Mar 9, 2026, 1:30 PM CST

Medeon Biodesign Revenue

Medeon Biodesign had revenue of 92.30M TWD in the quarter ending September 30, 2025, a decrease of -11.93%. This brings the company's revenue in the last twelve months to 381.90M, up 40.96% year-over-year. In the year 2024, Medeon Biodesign had annual revenue of 292.81M with 49.19% growth.

Revenue (ttm)
381.90M
Revenue Growth
+40.96%
P/S Ratio
21.33
Revenue / Employee
9.79M
Employees
39
Market Cap
8.15B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024292.81M96.55M49.19%
Dec 31, 2023196.26M-102.05M-34.21%
Dec 31, 2022298.32M229.36M332.61%
Dec 31, 202168.96M-54.10M-43.96%
Dec 31, 2020123.06M-330.71M-72.88%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bioteque 2.07B
Formosa Optical Technology 3.98B
Pacific Hospital Supply 2.41B
Vizionfocus 3.30B
St.Shine Optical 4.40B
SciVision Biotech 890.43M
Visco Vision 4.22B
Bionime 1.91B
Revenue Rankings